Professionnals
area
General
public access

News

Voir

F. nucleatum: prognostic marker for esophageal cancer?

Fusobacterium nucleatum levels in tumors may predict poorer responses to chemotherapy and act as a marker for poor prognosis in esophageal cancer. Could this lead to new antibiotic therapies targeting this bacterial species?   As the sixth leading cause of cancer death, esophageal cancer ...
Voir

Rectal cancer: F. nucleatum, a biomarker for relapse?

In locally advanced rectal cancer, chemotherapy prior to excision usually reduces the abundance of F. nucleatum on the surface of the tumor. However, the relapse rate for the disease may rest on the fate of this bacterium.   More and more evidence has come to signal Fusobacterium as an im...
Voir

Colorectal cancer: a bacterium is a key player in chemoresistance

According to a Chinese study, the presence of Fusobacterium nucleatum in tumor cells might significantly reduce the efficacy of one of the standard adjuvant chemotherapies for colorectal cancer.   The focus on gut dysbiosis was introduced into oncology research following the observation i...
  1. 1
  2. 2
  3. >

Pages

Publications

Medias